Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Magnetic Resonance Imaging

• Publication date

  2018-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jmri.26042PMID 29659077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TumourMetrics: a comprehensive clinical solution for the standardization of DCE-MRI analysis in research and routine use.

  2017cited by this paper
• Breast Tissue Metabolism by Magnetic Resonance Spectroscopy

  2017cited by this paper
• Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy

  2016cited by this paper
• Biology and Management of Patients With Triple-Negative Breast Cancer.

  2016cited by this paper
• Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer

  2016cited by this paper
• Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?

  2014cited by this paper
• Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis.

  2013cited by this paper
• Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis.

  2012cited by this paper
• Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS

  2012cited by this paper
• Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.

  2011cited by this paper
• In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Vascular characterisation of triple negative breast carcinomas using dynamic MRI

  2011cited by this paper
• Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI)

  2010cited by this paper
• Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method

  2010influential reference
• Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy.

  2009cited by this paper
• Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

  2008cited by this paper
• What is triple-negative breast cancer?

  2008cited by this paper
• Triple-negative breast cancer.

  2008cited by this paper
• Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

  2008cited by this paper
• Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

  2007cited by this paper
• Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.

  2006cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group.

  2005cited by this paper
• Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

  2005cited by this paper
• Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

  2004cited by this paper
• Determination of optimal angles for variable nutation proton magnetic spin‐lattice, T1, and spin‐spin, T2, relaxation times measurement

  2004cited by this paper
• Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

  2003cited by this paper
• The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

  2003cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

  2000cited by this paper
• Tumour phospholipid metabolism

  1999cited by this paper
• Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

  1999cited by this paper
• Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

  1998cited by this paper
• Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.

  1995cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• Statistics in Medicine: Calculating confidence intervals for some non-parametric analyses

  1988cited by this paper
• Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.

  1984cited by this paper
• Statistical guidelines for contributors to medical journals.

  1983cited by this paper

• Early prediction of pathologic complete response to neoadjuvant chemotherapy based on longitudinal total choline of MR spectroscopy in patients with breast cancer

  2026cites this paper
• Resistance to neoadjuvant chemotherapy in breast cancers: a metabolic perspective

  2025cites this paper
• Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism

  2022cites this paper
• MR spectroscopy in breast cancer metabolomics

  2021cites this paper
• Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images

  2020cites this paper
• Role of MRI to Assess Response to Neoadjuvant Therapy for Breast Cancer

  2020cites this paper
• The role of magnetic resonance imaging on evaluating response of neoadjuvant therapy for breast cancer

  2020cites this paper
• Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI

  2019cites this paper
• Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer

  2019influential citation
• Imaging of cancer lipid metabolism in response to therapy

  2019cites this paper
• Alteration in lipid composition differentiates breast cancer tissues: a 1H HRMAS NMR metabolomic study

  2018cites this paper
• Can Multi-Parametric MR Based Approach Improve the Predictive Value of Pathological and Clinical Therapeutic Response in Breast Cancer Patients?

  2018cites this paper